Qi-feng J. Chen

State Key Laboratory Of Oncology In South China
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications

Transarterial Chemoembolization Plus Thermal Ablation in Unresectable Hepatocellular Carcinoma: The Phase 3 TORCH Randomized Clinical Trial.

Transarterial Chemoembolization Plus Thermal Ablation in Unresectable Hepatocellular Carcinoma: The Phase 3 TORCH Randomized Clinical Trial.

Journal: JAMA oncology
Published: July 30, 2026

Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in the Era of Systemic Therapies (2020-2025).

Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in the Era of Systemic Therapies (2020-2025).

Journal: Liver cancer
Published: October 12, 2025

Hepatic Artery Infusion Chemotherapy for Cholangiocarcinoma in 2025.

Hepatic Artery Infusion Chemotherapy for Cholangiocarcinoma in 2025.

Journal: Liver cancer
Published: October 08, 2025

Hepatocellular carcinoma surveillance: a health economic evaluation.

Hepatocellular carcinoma surveillance: a health economic evaluation.

Journal: Clinical and molecular hepatology
Published: September 19, 2025

Reply to correspondence on "Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to contrast-enhanced computed tomography".

Reply to correspondence on "Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to contrast-enhanced computed tomography".

Journal: Clinical and molecular hepatology
Published: September 11, 2025

Immunotherapy versus lenvatinib in hepatocellular carcinoma: the need for granular data and prospective validation.

Immunotherapy versus lenvatinib in hepatocellular carcinoma: the need for granular data and prospective validation.

Journal: Journal for immunotherapy of cancer
Published: July 19, 2025

Beyond diagnostic accuracy: Economic and clinical considerations for NC-MRI in late HCC recurrence surveillance: Letter to the editor on "Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to contrast-enhanced computed tomography".

Beyond diagnostic accuracy: Economic and clinical considerations for NC-MRI in late HCC recurrence surveillance: Letter to the editor on "Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to contrast-enhanced computed tomography".

Journal: Clinical and molecular hepatology
Published: July 13, 2025

In-depth analysis of AFP trajectories in HCC: bridging gaps in survival data and clinical applicability.

In-depth analysis of AFP trajectories in HCC: bridging gaps in survival data and clinical applicability.

Journal: International journal of surgery (London, England)
Published: June 30, 2025

Advancing VR therapy research: strengthening health economic analysis in postoperative pain management.

Advancing VR therapy research: strengthening health economic analysis in postoperative pain management.

Journal: International journal of surgery (London, England)
Published: June 28, 2025

Interventional arterial chemotherapy versus sorafenib for advanced hepatocellular carcinoma in China: a health economic evaluation of open-label, randomised, phase 3 study.

Interventional arterial chemotherapy versus sorafenib for advanced hepatocellular carcinoma in China: a health economic evaluation of open-label, randomised, phase 3 study.

Journal: BMJ open
Published: May 28, 2025

Children's hepatoblastoma: gender and infant age demand focus in the global burden of disease study 2021.

Children's hepatoblastoma: gender and infant age demand focus in the global burden of disease study 2021.

Journal: Hepatology international
Published: May 07, 2025

The Synergistic Mechanisms and Prospects of Transarterial Chemoembolization Combined with Immunotherapy for Hepatocellular Carcinoma.

The Synergistic Mechanisms and Prospects of Transarterial Chemoembolization Combined with Immunotherapy for Hepatocellular Carcinoma.

Journal: Journal of hepatocellular carcinoma
Published: December 30, 2024
Showing 1-12 of 42

Last Updated: 09/26/2026